Abstract
We tested the hypothesis that Chinese patients have a coagulation profile that is less prothrombotic than that of Caucasian counterparts after the Fontan procedure by determining the type and prevalence of anticoagulant and procoagulant deficiencies in Chinese patients and comparing the findings to those previously reported in Caucasian series. The liver function and coagulation factors were assessed in 21 ethnic Chinese patients, aged 17.0 ± 5.6 years, at 10.7 ± 4.0 years after the Fontan procedure. The results were compared to those of 21 age-matched Chinese controls with minor congenital heart disease. The prevalence of coagulation factor deficiencies in our patients was further compared to that reported in Caucasian patients. When compared with controls, patients had significantly lower protein C (p = 0.014), factors II (p = 0.024), V (p < 0.001), VII (p < 0.001), IX (p = 0.036), and X (p < 0.001), and higher bilirubin (p = 0.001) levels. The prevalence of protein C deficiency was 9.5%, whereas those of factor II, V, VII, IX, and X deficiencies were 0, 66.7, 9.5, 0, and 57.1%, respectively. When compared with Caucasian data, our data showed a significantly lower prevalence of protein C, total protein S, antithorombin III, factor II, and factor VII deficiencies. Furthermore, the previously reported increase in factor VIII levels was not found. In contrast, the prevalence of factor X deficiency was higher in our patients. This study provides the first evidence of ethnic differences in coagulation factor abnormalities after the Fontan procedure. The imbalance between procoagulant and anticoagulant pathways in Chinese patients favors a bleeding, rather than a thrombotic, tendency.
Similar content being viewed by others
References
Balling G, Vogt M, Kaemmerer H, et al. (2000) Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 119:745–751
Bull K (1998) The Fontan procedure: lessons from the past. Heart 79:213–214
Chan KY, Yuen ST, Ng TH, Ng WF (1991) An autopsy study of pulmonary thromboembolism in Hong Kong Chinese. Pathology 23:181–184
Chan KY, Yuen ST, Wong MP (1997) Clinicopathological pattern of pulmonary thromboembolism in Chinese autopsy patients: comparison with Caucasian series. Pathology 29:263–266
Chan LC, Bourke C, Lam CK, et al (1996) Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors–correlation with absence of Arg 506–Gln mutation of Factor V gene. Thromb Haemost 75:522–523
Cheung YF, Chay GW, Chiu CS, Cheng LC (2005) Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure. Int J Cardiol, 19 July 2005; Epub
Cromme-Dijkhuis AH, Henkens CMA, Bijleveld CMA, et al (1990) Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 336:1087–1090
Cromme-Dijkhuis AH, Hess J, Hählen K, et al (1993) Specific sequelae after Fontan operation at mid- and long-term follow-up. J Thorac Cardiovasc Surg 106:1126–1132
Dobell AR, Trusler GA, Smallhorn JF, Williams WG (1986) Atrial thrombi after the Fontan operation. Ann Thorac Surg 42:664–667
Driscoll DJ, Offord KP, Feldt RH, et al. (1992) Five- to fifteen-year follow-up after Fontan operation. Circulation 85:469–496
Fletcher SE, Case CL, Fyfe DA, Gillette PC (1991) Clinical spectrum of venous thrombi in the Fontan patient. Am J Cardiol 68:1721–1722
Fontan F, Kirklin JW, Fernandez G, et al (1990) Outcome after a “perfect” Fontan operation. Circulation 81:1520–1536
Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne EA (1994) Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 58:1409–1414
Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E (1997) Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 113:989–993
Kaulitz R, Luhmer I, Bergmann F, Rodeck B, Hausdorf G (1997) Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 78:154–159
Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155
Lao TT, Yuen PM, Yin JA (1989) Protein S and protein C levels in Chinese women during pregnancy, delivery and the puerperium. Br J Obstet Gynaecol 96:167–170
Manning PB, Mayer JE, Wernovsky G, Fishberger SB, Walsch EP (1996) Staged operation to Fontan increased the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg 111:833–840
Monagle P, Cochrane A, McCrindle B, et al. (1998) Thromboembolic complications after Fontan procedures — the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 115:493–498
Odegard KC, McGowan FX, Zurakowski D, et al. (2002) Coagulation factor abnormalities following the Fontan procedure: factor VIII is increased and may predispose to thrombosis. J Am Coll Cardiol 106:II-523
Rauch R, Ries M, Hofbeck M, et al. (2000) Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 83:678–682
Ravn HB, Hjortdal VE, Stenbog EV, et al. (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85:61–65
van Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82:40–46
Wright EM, Royston P (1999) Calculating reference intervals for laboratory measurements. Stat Methods Med Res 8:93–112
Acknowledgment
This study was funded by the CRCG Research Grant, Faculty of Medicine, The University of Hong Kong.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheung, YF., Chay, G. & Ma, E. Ethnic Differences in Coagulation Factor Abnormalities After the Fontan Procedure. Pediatr Cardiol 27, 96–101 (2006). https://doi.org/10.1007/s00246-005-1031-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-005-1031-3